Makoto Fukana

Title: The Innovative Contributions of Makoto Fukana

Introduction: Makoto Fukana is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of pharmaceutical sciences. His work has led to advancements in the production of fine particles of aripiprazole anhydride crystals, which are crucial for various medical applications.

Latest Patents: Makoto Fukana holds a patent for a novel method for producing fine particles of aripiprazole anhydride crystals B. This method involves several steps, including heating and dissolving crude aripiprazole in a lower alcohol, cooling the mixture to precipitate crystals, wet-milling the crystals in a slurry, and finally, solid-liquid separation to obtain the desired crystals. This innovative approach enhances the efficiency and quality of aripiprazole production.

Career Highlights: Fukana is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to contribute to pharmaceutical innovations. His expertise in the field has made him a valuable asset to the company and the industry as a whole. He has been instrumental in developing methods that improve the production processes of pharmaceutical compounds.

Collaborations: Throughout his career, Makoto Fukana has collaborated with notable colleagues, including Takuji Bando and Katsuhiko Yano. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion: Makoto Fukana's work exemplifies the spirit of innovation in the pharmaceutical industry. His patented method for producing fine particles of aripiprazole anhydride crystals showcases his commitment to advancing medical science. His contributions will undoubtedly have a lasting impact on the field.